Robert G. Hart

Active 1981–2025

Also published as
Robert G Hart
151
Papers
43,117
Citations
102
h-index
151
i10-index

Citations

Citations per year for Robert G. Hart1890: 1 citations1970: 1 citations1976: 1 citations1982: 1 citations1983: 1 citations1984: 1 citations1985: 7 citations1986: 13 citations1987: 15 citations1988: 15 citations1989: 17 citations1990: 27 citations1991: 20 citations1992: 26 citations1993: 25 citations1994: 30 citations1995: 30 citations1996: 34 citations1997: 41 citations1998: 55 citations1999: 79 citations2000: 95 citations2001: 141 citations2002: 99 citations2003: 146 citations2004: 138 citations2005: 163 citations2006: 272 citations2007: 214 citations2008: 239 citations2009: 172 citations2010: 219 citations2011: 303 citations2012: 325 citations2013: 263 citations2014: 340 citations2015: 254 citations2016: 302 citations2017: 297 citations2018: 267 citations2019: 1,029 citations2020: 1,013 citations2021: 889 citations2022: 698 citations2023: 448 citations2024: 780 citations2025: 300 citations2026: 19 citations1891–1969: no citations, so these years are not shown1971–1975: no citations, so these years are not shown1977–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,912 citing papers, 20.3% of this breakdownUnited Kingdom: 1,416 citing papers, 9.9% of this breakdownCanada: 918 citing papers, 6.4% of this breakdownGermany: 885 citing papers, 6.2% of this breakdownItaly: 739 citing papers, 5.1% of this breakdownChina: 547 citing papers, 3.8% of this breakdownNetherlands: 534 citing papers, 3.7% of this breakdownFrance: 493 citing papers, 3.4% of this breakdownAustralia: 457 citing papers, 3.2% of this breakdownDenmark: 435 citing papers, 3% of this breakdownSweden: 416 citing papers, 2.9% of this breakdownSpain: 375 citing papers, 2.6% of this breakdown
0%20.3%Other 29.5%

Fields

  • Medicine92.7%
  • Biochemistry, Genetics and Molecular Biology2.1%
  • Neuroscience1.3%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Immunology and Microbiology0.6%
  • Health Professions0.5%
  • Other2.2%

Topics

  • Atrial Fibrillation Management and Outcomes15.4%
  • Acute Ischemic Stroke Management7.6%
  • Venous Thromboembolism Diagnosis and Management4.6%
  • Cardiac Arrhythmias and Treatments4.1%
  • Antiplatelet Therapy and Cardiovascular Diseases3.9%
  • Cerebrovascular and Carotid Artery Diseases3.7%
  • Other60.7%

Coauthors

All papers

Open in search
  1. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Peter Verhamme, Dragoş Vinereanu, Jae‐Hyung Kim, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Philippe Gabríel Steg, Kaj Metsärinne, Nancy Cook Bruns, Frank Misselwitz, Edmond Chen, Darryl P. Leong, Salim Yusuf - New England Journal of Medicine 2017 cited by 2,412

  2. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

    Authors: , , - Annals of Internal Medicine 2007 cited by 4,802

  3. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raf Brouns, Matthias Endres, Keith W. Muir, Natan M. Bornstein, Şerefnur Öztürk, Martin O’Donnell, Matthys M. De Vries Basson, Guillaume Paré, Calin Pater, Bodo Kirsch, Patrick Sheridan, Gary Peters, Jeffrey I. Weitz, W. Frank Peacock, Ashkan Shoamanesh, Oscar Benavente, Campbell Joyner, Ellison Themeles, Stuart J. Connolly - New England Journal of Medicine 2018 cited by 1,010

  4. Apixaban in Patients with Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rizwan Afzal, Salim Yusuf - New England Journal of Medicine 2011 cited by 2,420

  5. Embolic strokes of undetermined source: the case for a new clinical construct

    Authors: , , , , , , , - The Lancet Neurology 2014 cited by 1,662

  6. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf - Gastroenterology 2019 cited by 477

  7. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura Heenan, Lizhen Xu, Stuart J. Connolly, Robert G. Hart - The Lancet 2022 cited by 193

  8. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert G. Hart, Salim Yusuf, JORGELINA SALA, Luis R Cartasegna, MARISA VICO, Miguel Hominal, Eduardo Hasbani, Alberto Caccavo, Cesar Javier Zaidman, DANIEL VOGEL, Adrian D. Hrabar, Pablo Schygiel, Carlos Alberto Cuneo, Hugo A Luquez, Ignacio MacKinnon, Rodolfo Andrés Ahuad Guerrero, Juan Pablo Costabel, INES PALMIRA BARTOLACCI, Oscar Montaña, María Antonietta Barbieri, Oscar Gómez Vilamajó, RUBEN OMAR GARCIA DURAN, Lilia Beatriz Schiavi, Marcelo Garrido, ADRIAN INGARAMO, Anselmo P. Bordonava, MARIA JOSE PELAGAGGE, LEONARDO NOVARETTO, JUAN PABLO ALBISU DI GENNERO, LUZ MARIA IBANEZ SAGGIA, MOIRA ALVAREZ, Néstor A. Vita, Stella M. Macı́n, Ricardo D. Dran, Marcelo Cardona, Luis Guzman, RODOLFO JUAN SARJANOVICH, Jesus Cuadrado, SEBASTIAN NANI, MARCOS RAUL LITVAK BRUNO, Carolina Chacón, Laura Maffei, Diego Grinfeld, NATALIA VENSENTINI, CLAUDIO RODOLFO MAJUL, Héctor Luciardi, PATRICIA DEL CARMEN GONZALEZ COLASO, FREDY ANTONI FERRE PACORA, PAUL VAN DEN HEUVEL, Peter Verhamme, Bavo Ector, PHILIPPE DEBONNAIRE, Philippe van de Borne, JEAN LEROY, Herman Schroë, Pascal Vranckx, Ivan Elegeert, E Hoffer, KARL DUJARDIN, CLARISSE INDIO DO BRASIL, Dalton Bertolim Précoma, JOSE ANTONIO ABRANTES, Euler Roberto Fernandes Manenti, Gilmar Reis, José Francisco Kerr Saraiva, Lília Nigro Maia, Mauro Esteves Hernandes, Paulo Roberto Ferreira ROSSI, Fabio Rossi dos Santos, Sérgio Luiz Zimmermann and 544 more - The Lancet 2017 cited by 880

  9. Embolic Stroke of Undetermined Source

    Authors: , , , , - Stroke 2017 cited by 548

  10. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

    Authors: , , , , , , , , , , , , - Kidney International 2011 cited by 925

  11. Guidelines for the Primary Prevention of Stroke

    Authors: , , , , , , , , , , , , , , , , , - Stroke 2010 cited by 1,285

  12. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES

    Authors: , , , , , , , , , , , , - European Heart Journal 2014 cited by 313

  13. The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 cited by 145

  14. Atrial Fibrillation and Cognitive Function

    Authors: , , , , - Journal of the American College of Cardiology 2019 cited by 198

  15. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabelle C. Van Gelder, L. Jaap Kappelle, Gabriël J.E. Rinkel, Roger E. G. Schutgens, Pooja Khatri, Robin Conwit, Guido J. Falcone, Jordan Elm, Craig S. Anderson, Lili Song, Jeyaraj Pandian, Robert G. Hart, Mukul Sharma, Hany Aref, Wadea Tarhuni, J. Martí Fàbregas, Hans‐Christoph Diener, Matthias Endres, Robin Lemmens, Sun U. Kwon, Byung‐Chul Lee, Sebastián F. Ameriso, Truman J. Milling, Scott E. Kasner, Robert Mikulík, Denis Xavier, Ronny Beer, Danilo Toni, Jens Eckstein, David Seiffge, José M. Ferro, Georgios Tsivgoulis, Sanjib Kumar Sharma, Chia Wei-Liou, Stefan H. Hohnloser, Aristeidis H. Katsanos, Jackie Bosch, Jeff S. Healey, John W. Eikelboom, Alexander V. Khaw, David J. Gladstone, Aleksandra Pikula, Shelagh B. Coutts, Eric E. Smith, Kenneth Butcher, Thalia S. Field, Laura Gioia, Christian Stapf, Omid Halse, Peter Ringleb, Christian Enzinger, Igor Sibon, Joan Montaner, Valeria Caso, Peter U. Heuschmann, Gregory Y.H. Lip, Walter E. Haefeli, Stefanie Debette, Martin Dennis, Torgeir Bruun Wyller, Ole Morten Rønning, Helle Eilertsen, Hege Ihle‐Hansen, Else Charlotte Sandset, Johanna Pennlert, Eva‐Lotta Glader, Christina Kruuse, Per Wester, Maria Carlsson, Elisabeth Forfang - The Lancet Neurology 2023 cited by 63

  16. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf - Gastroenterology 2019 cited by 154

  17. Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2019 cited by 207

  18. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grethe Andersen, Peter D. Schellinger, Konstantinos Kostulas, Katharina S. Sunnerhagen, Boris Keselman, Eleni Korompoki, Jan Purrucker, Pooja Khatri, William Whiteley, Eivind Berge, Michael V. Mazya, Diederik W.J. Dippel, Satu Mustanoja, Mads Rasmussen, Åsa Kuntze Söderqvist, Irene Escudero‐Martínez, Thorsten Steiner - European Stroke Journal 2019 cited by 173

  19. Review and update of the concept of embolic stroke of undetermined source

    Authors: , , , , , - Nature Reviews Neurology 2022 cited by 106

  20. Stroke Prevention in Atrial Fibrillation

    Authors: , , , - Circulation 2020 cited by 90

  21. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , María Verónica Marroquín, Tissa Wijeratne, Elizabeth A. Mackey, Elyce Warburton, Fatemeh Rezania, Timothy Kleinig, Erin Kelly, Jackson D. Harvey, Sumiti Nayar, Kanjana Perera, Thalia S. Field, Shelagh B. Coutts, Dominic Tse, Eric E. Smith, Ericka Teleg, Michael D. Hill, Ravinder Signh, Jennifer Mandzia, Aleksandra Pikula, Grant Stotts, Verónica V. Olavarría, Enrico Mazzon, Elena Meseguer, Fernando Pico, Bernd Kallmuenzer, Julia Koehn, Kosmas Macha, Sebastian S. Roeder, Christian H. Nolte, Ida Randus, Jonas Bader, Rohat Geran, Serdar Tuetuencue, Günter Seidel, Kuecken Detmar, Angel Antonio Arauz Gongora, Anna Członkowska, Dorota Kozera, Marcin Głuszkiewicz, Michał Karliński, Waldemar Brola, Malgorzata Ziomek, Matthys Basson, Maria E. Pretorius, Juan F. Arenillas, Elisa Cortijo Garcia, Joan Martí‐Fábregas, Meritxell Gomis, Lucía Muñoz-Narbona, Marcel Arnold, Basel Maamari, Jan Vynckier, Martina Göldlin, Simon Jung, Thomas Horvath, Thomas R. Meinel, Hugh S. Markus, J Chembala, Christine Roffe, Janaka Weerathunga, Nenette Abano, Phillip Ferdinand, Roland Veltkamp, Abid Malik, Ambreen Ali Sheikh, Lucio D’Anna, Omid Halse, Soma Banerjee, Urszula Bojaryn, Ali Ali and 29 more - JAMA Neurology 2022 cited by 88

  22. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

    Authors: , , , - Annals of Internal Medicine 1999 cited by 1,639

  23. Primary Prevention of Ischemic Stroke

    Authors: , , , , , , , , , , , , , , - Stroke 2006 cited by 1,367

  24. Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: I. Reduced Flow Velocity in the Left Atrial Appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)

    Authors: , , , , , , - Journal of the American Society of Echocardiography 1999 cited by 364